Skip to main content

Lupus Anticoagulant Eval w/reflex

CPT/HCPCS 85613, 85730
Order Code CH798
Turnaround Time 24-48 hours
Test Includes

PTT-LA and dRVVT with Reflex Confirmations If PTT-LA Screen is prolonged (>40 seconds), then Hexagonal Phase Confirmation will be performed at an additional charge (CPT code(s): 85598). If Hexagonal Phase Confirmation is positive or weakly positive, then Thrombin Clotting Time will be performed at an additional charge (CPT code(s): 85670). If dRVVT Screen is prolonged (>45 seconds), then dRVVT Confirm will be performed at an additional charge (CPT code(s): 85597). If dRVVT Confirm is positive, then dRVVT 1:1 Mixing Study will be performed at an additional charge (CPT code(s): 85613).

Specimen Requirements
Specimen Source
Transport Container
(Specimen Container)

3.2% sodium citrate (light blue)

Preferred Specimens
Frozen Plasma from Na-Citrate
Minimum Volume (uL)
Collection Instructions
(Transport Temperature)
Transport Frozen
Specimen Stability
Temperature Period
Room temperature Unacceptable
Frozen 30 days
Reject Criteria


Special Instructions

Platelet-poor plasma: Centrifuge light blue-top tube for 15 minutes at approximately 1500 g within 60 minutes of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial. Plasma must be free of platelets

Test Details
Clot detection
Clinical Significance

Lupus anticoagulants (LA) are members of a family of antibodies with phospholipid-protein specificity. LA may be defined as an immunoglobulin, IgG or IgM or a mixture of both, that interferes with one or more of the in-vitro phospholipid (PL) dependent tests of coagulation. These antibodies are not associated with a hemorrhagic diathesis, but rather have been linked to thrombotic events. In addition to thrombosis other clinical complications have been associated with the presence of LA. These include strokes, nonbacterial thrombotic endocarditis, livedo reticularis and a variety of obstetrical complications such as intrauterine fetal death, recurrent spontaneous abortion, fetal growth retardation, early onset preeclampsia and chorea gravidarum.

Reference Ranges

See Laboratory Report